Platelet-to-high-density lipoprotein ratio (PHR) as a predictive biomarker for gastrointestinal cancers - evidence from NHANES
Favorite
Share
More Options
11

Open in WPS to view all 11 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
